Coherus Oncology, Inc.
CHRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001512762
No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Coherus Oncology, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 174 | 1 | 161 | −12 |
| Shares | 77.4M | 1.58K | 78.6M | +1.26M (+1.6%) |
| Value | $743.4M | $15.1K | $622.7M | −$120.7M (−16.2%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Coherus Oncology, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 150,000 | $1.19M | 0.01% |
| Wellington Management Group LLP | 95,895 | $759.5K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 88,022 | $697.1K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 82,775 | $655.6K | 0.01% |
| Velan Capital Investment Management LP | 82,605 | $654.2K | 0.70% |
| Gsa Capital Partners LLP | 77,039 | $610.0K | 0.08% |
| Legato Capital Management LLC | 59,038 | $467.6K | 0.09% |
| XTX Topco Ltd | 48,756 | $386.1K | 0.08% |
| Man Group plc | 35,685 | $282.6K | 0.00% |
| Jefferies Financial Group Inc. | 24,625 | $195.0K | 0.00% |
| Bayesian Capital Management, LP | 23,800 | $188.5K | 0.03% |
| Walleye Capital LLC | 16,467 | $130.4K | 0.00% |
| Landscape Capital Management, L.L.C. | 16,058 | $127.2K | 0.02% |
| Steel Peak Wealth Management LLC | 16,000 | $126.7K | 0.01% |
| Wolverine Trading, LLC | 15,299 | $121.0K | 0.00% |
| Alpine Global Management, LLC | 12,714 | $101.0K | 0.03% |
| Advisory Services Network, LLC | 9,550 | $75.6K | 0.00% |
| IFP Advisors, Inc | 1,000 | $16.0K | 0.00% |
| Belpointe Asset Management LLC | 1,991 | $15.8K | 0.00% |
Sold out (31)
Institutions that held Coherus Oncology, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (1)
Institutions that held Coherus Oncology, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| American Portfolios Advisors | 1,576 | $15.1K |